Predict your next investment

Venture Capital
nbgipe.com/ventures

See what CB Insights has to offer

Investments

30

Portfolio Exits

7

Funds

1

About NBGI Ventures

NBGI Ventures manages a EUR 60 million fund based in the United Kingdom, focused on investments in European companies in the IT, energy and medtech sectors. NBGI Ventures has a team of 4 professionals with offices in London and Athens and considers investments across Europe, including Greece.

NBGI Ventures Headquarters Location

Old Change House 128 Queen Victoria Street

London, England, EC4V 4BJ,

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest NBGI Ventures News

Symetis Raises CHF25M in Equity Financing

Mar 26, 2015

Published On October 7, 2010 | Symetis SA , a Lausanne, Switzerland-based company developing new transcatheter aortic valve implantation (TAVI) systems, has raised CHF25m (approximately $25.8m) in new financing. The round was co-led by Endeavour Vision and NBGI Ventures, with participation from existing investors Truffle Capital, Novartis Venture Fund, Wellington Partners, Vinci Capital – Renaissance PME, Banexi Ventures and BiomedInvest. As also stated by Dr. Jacques R. Essinger, CEO of Symetis, this financing round gives the company the means to commercially launch its first product, conduct Acurate TF™ clinical validation and initiate the US approval process. The company announced in September positive preliminary results from its first-in-man clinical study for its lead product Acurate TA™, a self-aligning, nitinol stented tissue heart valve. Acurate TA™ is designed for optimal trans-apical delivery, providing the physician with unmatched positioning tolerance and ease of use. In parallel, Symetis is conducting pre-clinical validation of Acurate TF™, a trans-femoral TAVI solution based on similar design principles, scheduled to enter clinical trials in 2011. In conjunction with the funding, Damien Tappy, General Partner at Endeavour Vision, and John E. Milad, Investment Manager at NBGI Ventures, will both join the company’s board of directors. Symetis also appointed Eric Milledge as Chairman of the board. FinSMEs

NBGI Ventures Investments

30 Investments

NBGI Ventures has made 30 investments. Their latest investment was in Quanta Dialysis Technology as part of their Series B on November 11, 2014.

CBI Logo

NBGI Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/3/2014

Series B

Quanta Dialysis Technology

$43.12M

No

1

4/21/2014

Series D

EPIX Therapeutics

$7.3M

No

2

4/15/2013

Unattributed VC

DySIS Medical

$11.4M

Yes

1

4/4/2013

Series D

Subscribe to see more

$99M

Subscribe to see more

10

9/8/2011

Series C

Subscribe to see more

$99M

Subscribe to see more

0

Date

11/3/2014

4/21/2014

4/15/2013

4/4/2013

9/8/2011

Round

Series B

Series D

Unattributed VC

Series D

Series C

Company

Quanta Dialysis Technology

EPIX Therapeutics

DySIS Medical

Subscribe to see more

Subscribe to see more

Amount

$43.12M

$7.3M

$11.4M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

2

1

10

0

NBGI Ventures Portfolio Exits

7 Portfolio Exits

NBGI Ventures has 7 portfolio exits. Their latest portfolio exit was EPIX Therapeutics on January 24, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/24/2019

Acquired

$99M

1

6/21/2017

IPO

Subscribe to see more

$99M

Subscribe to see more

10

3/30/2017

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

7/9/2015

IPO

Subscribe to see more

$99M

Subscribe to see more

10

8/22/2014

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/24/2019

6/21/2017

3/30/2017

7/9/2015

8/22/2014

Exit

Acquired

IPO

Acquired

IPO

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

NBGI Ventures Fund History

1 Fund History

NBGI Ventures has 1 fund, including NBGI Technology Fund II LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

11/1/2007

NBGI Technology Fund II LP

Early-Stage Venture Capital

Open

$36.06M

1

Closing Date

11/1/2007

Fund

NBGI Technology Fund II LP

Fund Type

Early-Stage Venture Capital

Status

Open

Amount

$36.06M

Sources

1

NBGI Ventures Team

2 Team Members

NBGI Ventures has 2 team members, including current Chief Executive Officer, Graham Thomas.

Name

Work History

Title

Status

Aris Constantinides

Founder

Current

Graham Thomas

Chief Executive Officer

Current

Name

Aris Constantinides

Graham Thomas

Work History

Title

Founder

Chief Executive Officer

Status

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.